The store will not work correctly when cookies are disabled.
2-(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-benzooxazole
ID: ALA168978
PubChem CID: 44380086
Max Phase: Preclinical
Molecular Formula: C15H11NO3
Molecular Weight: 253.26
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1ccc2c(c1)OCC(c1nc3ccccc3o1)O2
Standard InChI: InChI=1S/C15H11NO3/c1-2-6-11-10(5-1)16-15(19-11)14-9-17-12-7-3-4-8-13(12)18-14/h1-8,14H,9H2
Standard InChI Key: CWCFMJLMWLEGKJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 22 0 0 0 0 0 0 0 0999 V2000
6.2625 -3.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3417 -2.7167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5417 -3.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0125 -3.8792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8250 -3.5292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1500 -2.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8250 -5.1917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5625 -3.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1125 -3.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5417 -4.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1125 -4.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5625 -1.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3792 -3.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4000 -3.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4000 -5.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8000 -2.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3875 -1.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6875 -3.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6875 -4.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 1 1 0
5 3 1 0
6 2 1 0
7 10 1 0
8 4 1 0
9 5 1 0
10 3 1 0
11 7 1 0
12 6 1 0
13 8 1 0
14 9 2 0
15 11 2 0
16 13 2 0
17 12 2 0
18 14 1 0
19 15 1 0
6 8 2 0
9 11 1 0
16 17 1 0
19 18 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 253.26 | Molecular Weight (Monoisotopic): 253.0739 | AlogP: 3.34 | #Rotatable Bonds: 1 |
Polar Surface Area: 44.49 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.84 | CX LogD: 2.84 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.67 | Np Likeness Score: -0.50 |
References
1. Chapleo CB, Myers PL, Butler RC, Doxey JC, Roach AG, Smith CF.. (1983) alpha-adrenoreceptor reagents. 1. Synthesis of some 1,4-benzodioxans as selective presynaptic alpha 2-adrenoreceptor antagonists and potential antidepressants., 26 (6): [PMID:6133953] [10.1021/jm00360a008] |